SN

Surendra Nath Tiwari

Active Director Director DIN 09386894
DIN 09386894 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Surendra Nath Tiwari

Data last updated:

Surendra Nath Tiwari is a Director at Vimco Drugs Private Limited (since 2021). The company operates in Healthcare.

DIN 09386894
Primary Designation Director
Industry Healthcare
First Appointment 02 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vimco Drugs Private Limited U24304UP2021PTC154955
Director02 Nov 20212021Active

Board colleagues of Surendra Nath Tiwari

Directorship timeline

Open interactive timeline →
Vimco Drugs Private Limited
Premium access

Shareholding and investment profile for Surendra Nath Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Nath Tiwari

Surendra Nath Tiwari currently holds 1 directorship: Vimco Drugs Private Limited (Director, since 02 Nov 2021).

Surendra Nath Tiwari was first appointed on 02 Nov 2021 as Director at Vimco Drugs Private Limited.

The current boards of Surendra Nath Tiwari's companies include Rajendra Mani Tiwari (Vimco Drugs Private Limited), Rajneesh Kumar Mishra (Vimco Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available